Prospective Evaluation of Bleeding Risk of Anticoagulant and Anti-platelet Therapy

Pain Management Center of Paducah

Status: Completed

Conditions: Bleeding

Treatments: Drug: Antithrombotics

Study type: Observational

Funder types: Other

Identifiers

NCT00625248

protocol 18

Details and patient eligibility

About

This study will evaluate bleeding risk and differences in outcomes in patients receiving and not receiving anticoagulant or antiplatelet therapy

Full description

1. To evaluate bleeding risk in interventional procedures in patients with or without antiplatelet and/or anticoagulant therapy.
2. To evaluate differences in outcomes in patients not receiving any anticoagulant or antiplatelet therapy compared to patients receiving various types of drugs with anticoagulant or antiplatelet therapeutic effects.
3. To evaluate and compare the adverse event profiling all patients.

Enrollment: 12,000 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects undergoing interventional techniques. Subjects who were able to give voluntary, written informed consent.

Exclusion criteria

• All those things, patients on heparin, dextran, and low molecular heparin

Trial design

12,000 participants in 3 patient groups

no anthithrombotic

Description:

procedures where there were no antithrombotics

Treatment:

Drug: Antithrombotics

Antithrombotic - continued

Description:

patients who are on antithrombotics

Treatment:

Drug: Antithrombotics

Discontinued Antithrombotic

Description:

Patients who were on antithrombotics but have been discontinued

Treatment:

Drug: Antithrombotics